Flunixin Overview

Substance: Flunixin (CAS #–38677–85–9)

Annotation: In accordance with approved labeling; except that for use under 7 CFR part 205, the NOP requires a withdrawal period of at least two-times that required by the FDA

National List Citation: 7 CFR 205.603(9)

Date Listed: 2007

Sunset Date: 6/27/2017

Use and Brand Name Products: Inflammation and Pyrexia Treatment

T